目的:观察丹红注射液联合吡格列酮治疗非酒精性脂肪性肝炎的临床疗效。方法:57例非酒精性脂肪性肝炎患者给予丹红注射液30 ml,ivd,qd;,联合吡格列酮15 mg,po,qd,疗程2个月。观察治疗前后症状、体征、肝功能、血脂以及B超等变化。结果:治疗后患者证候、肝功能、血脂、B超检查结果改善均优于治疗前(P<0.01),总有效率82.4%。结论:丹红注射液联合吡格列酮治疗非酒精性脂肪性肝炎临床疗效较好。 Objective: To observe the clinical efficacy of Danhong injection combined with pioglitazone in the treatment of non-alcoholic steatohepatitis. Methods: 57 cases of non-alcoholic steatohepatitis were given Danhong injection 30 ml, ivd, qd ;, combined with pioglitazone 15 mg, po, qd, course of treatment for 2 months. Before and after treatment to observe the symptoms, signs, liver function, blood lipid and B ultrasound changes. Results: After treatment, the improvement of syndromes, liver function, blood lipids and B ultrasound were better than before treatment (P <0.01), and the total effective rate was 82.4%. Conclusion: Danhong injection combined with pioglitazone in the treatment of non-alcoholic steatohepatitis has better curative effect.